152 related articles for article (PubMed ID: 35729851)
1. Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock.
Scolari FL; Abelson S; Brahmbhatt DH; Medeiros JJF; Fan CS; Fung NL; Mihajlovic V; Anker MS; Otsuki M; Lawler PR; Ross HJ; Luk AC; Anker S; Dick JE; Billia F
Eur J Heart Fail; 2022 Sep; 24(9):1573-1582. PubMed ID: 35729851
[TBL] [Abstract][Full Text] [Related]
2. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
[TBL] [Abstract][Full Text] [Related]
3. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
[TBL] [Abstract][Full Text] [Related]
4. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
[TBL] [Abstract][Full Text] [Related]
5. Association of clonal haematopoiesis with severe postoperative complications in patients undergoing radical oesophagectomy.
Wang H; Yan H; Chen W; Tang H; Pei Y; Shan Q; Cang J; Miao C; Tan L; Tan L
Br J Anaesth; 2024 Feb; 132(2):277-284. PubMed ID: 38044238
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction.
Wang S; Hu S; Luo X; Bao X; Li J; Liu M; Lv Y; Zhao C; Zeng M; Chen X; Unsworth A; Jones S; Johnson TW; White SJ; Jia H; Yu B
EBioMedicine; 2022 Apr; 78():103964. PubMed ID: 35339897
[TBL] [Abstract][Full Text] [Related]
7. Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.
Böhme M; Desch S; Rosolowski M; Scholz M; Krohn K; Büttner P; Cross M; Kirchberg J; Rommel KP; Pöss J; Freund A; Baber R; Isermann B; Ceglarek U; Metzeler KH; Platzbecker U; Thiele H
J Am Coll Cardiol; 2022 Oct; 80(16):1545-1556. PubMed ID: 36229091
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
9. Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke.
Arends CM; Liman TG; Strzelecka PM; Kufner A; Löwe P; Huo S; Stein CM; Piper SK; Tilgner M; Sperber PS; Dimitriou S; Heuschmann PU; Hablesreiter R; Harms C; Bullinger L; Weber JE; Endres M; Damm F
Blood; 2023 Feb; 141(7):787-799. PubMed ID: 36441964
[TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.
Scolari FL; Brahmbhatt DH; Abelson S; Medeiros JJF; Anker MS; Fung NL; Otsuki M; Calvillo-Argüelles O; Lawler PR; Ross HJ; Luk AC; Anker S; Dick JE; Billia F
Am J Transplant; 2022 Dec; 22(12):3078-3086. PubMed ID: 35971851
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock.
Sundermeyer J; Kellner C; Beer BN; Besch L; Dettling A; Bertoldi LF; Blankenberg S; Dauw J; Dindane Z; Eckner D; Eitel I; Graf T; Horn P; Jozwiak-Nozdrzykowska J; Kirchhof P; Kluge S; Linke A; Landmesser U; Luedike P; Lüsebrink E; Majunke N; Mangner N; Maniuc O; Möbius Winkler S; Nordbeck P; Orban M; Pappalardo F; Pauschinger M; Pazdernik M; Proudfoot A; Kelham M; Rassaf T; Reichenspurner H; Scherer C; Schulze PC; Schwinger RHG; Skurk C; Sramko M; Tavazzi G; Thiele H; Villanova L; Morici N; Winzer EB; Westermann D; Gustafsson F; Schrage B
Eur J Heart Fail; 2024 Feb; 26(2):432-444. PubMed ID: 37940139
[TBL] [Abstract][Full Text] [Related]
12. Five-year risk of heart failure and death following myocardial infarction with cardiogenic shock: a nationwide cohort study.
Lauridsen MD; Rorth R; Butt JH; Kristensen SL; Schmidt M; Moller JE; Hassager C; Torp-Pedersen C; Gislason G; Kober L; Fosbol EL
Eur Heart J Acute Cardiovasc Care; 2021 Mar; 10(1):40-49. PubMed ID: 33721017
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.
Xu E; Su K; Zhou Y; Gong L; Xuan Y; Liao M; Cao J; Li Y; Lu Y; Zhao Y; Chen F
J Cell Mol Med; 2021 Nov; 25(21):10279-10290. PubMed ID: 34658138
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction.
Wada H; Ogita M; Suwa S; Nakao K; Ozaki Y; Kimura K; Ako J; Noguchi T; Yasuda S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Wake M; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
Int Heart J; 2021 May; 62(3):520-527. PubMed ID: 33994511
[TBL] [Abstract][Full Text] [Related]
15. Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers.
Shi C; Aboumsallem JP; Suthahar N; de Graaf AO; Jansen JH; van Zeventer IA; Bracun V; de Wit S; Screever EM; van den Berg PF; Meijers WC; Gansevoort RT; Bakker SJL; van der Harst P; Silljé HHW; Huls G; de Boer RA
Eur J Heart Fail; 2023 Jan; 25(1):4-13. PubMed ID: 36221810
[TBL] [Abstract][Full Text] [Related]
16. Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock.
Jones TL; Tan MC; Nguyen V; Kearney KE; Maynard CC; Anderson E; Mahr C; McCabe JM
ESC Heart Fail; 2020 Jun; 7(3):1118-1124. PubMed ID: 32160418
[TBL] [Abstract][Full Text] [Related]
17. Clonal Hematopoiesis and the Heart: a Toxic Relationship.
Jensen JL; Easaw S; Anderson T; Varma Y; Zhang J; Jensen BC; Coombs CC
Curr Oncol Rep; 2023 May; 25(5):455-463. PubMed ID: 36920637
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock.
Hernandez-Montfort J; Sinha SS; Thayer KL; Whitehead EH; Pahuja M; Garan AR; Mahr C; Haywood JL; Harwani NM; Schaeffer A; Wencker D; Kanwar M; Vorovich E; Abraham J; Burkhoff D; Kapur NK
Circ Heart Fail; 2021 May; 14(5):e007924. PubMed ID: 33905259
[TBL] [Abstract][Full Text] [Related]
19. Admission levels of C-reactive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission.
Akkus MN; Polat G; Yurtdas M; Akcay B; Ercetin N; Cicek D; Doven O; Sucu N
Int Heart J; 2009 Jan; 50(1):33-45. PubMed ID: 19246845
[TBL] [Abstract][Full Text] [Related]
20. Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
Ghajar A; Ordonez CP; Philips B; Pinzon PQ; Fleming LM; Motiwala SR; Sriwattanakomen R; Ho JE; Grandin EW; Sabe M; Garan AR
Int J Cardiol; 2022 Nov; 367():45-48. PubMed ID: 36002041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
